IUPAC_name = (S)-1- [p- [2-(cyclopropylmethoxy)ethyl] phenoxy] -3-(isopropylamino)-2-propanol hydrochloride
CAS_number = 93221-48-8
PubChem = 60657
C = 18 | H = 29 | O = 3 | N = 1
molecular_weight = 342.472 g/mol
elimination_half-life = 20 hours
pregnancy_US = C
routes_of_administration = topical (ophthalmic)
Levobetaxolol or Levobetxolol hydrochloride is a drug used to lower the
pressurein the eyein treating conditions such as glaucoma. It is typically marketed as a 0.5% ophthalmic solutionunder the trade nameBetaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor( beta blocker.
Levobetaxolol inhibits the beta-1-adrenergic receptor. When applied topically, it reduces intra-ocular pressure (IOP) by 16-23% depending on time of day and the individual. It is indicated for IOP reduction in patients with open-angle glaucoma or ocular hypertension. Levobetaxolol has fewer cardiovascular side effects than other beta blockers.
Contraindications and side effects
Levobetaxolol should not be used by people who have
sinus bradycardia, atrioventricular block, cardiogenic shock, or overt cardiac failure.
The drug has been associated with
Wikimedia Foundation. 2010.